SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017)
SELLAS Life Sciences (SLS) posted quarterly Tax Rate of 0.85% for Q4 2017, up 37.05% quarter-over-quarter from 1.35% in Q3 2017.
SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Tax Rate for 2 consecutive years, with 0.85% the latest figure, recorded in Q4 2017.
- In Q4 2017, Tax Rate changed N/A year-over-year to 0.85%; the TTM figure through Dec 2017 stood at 1.06% (changed N/A YoY), while the FY2021 annual figure was 1.13%, up 103.0% from the prior year.
- Tax Rate climbed to 0.85% in Q4 2017 per SLS's latest filing, from 1.35% in the prior quarter.
- Across five years, Tax Rate topped out at 22.91% in Q1 2013 and bottomed at 19.13% in Q2 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -0.85% |
| Dec 31, 2017 | -0.85% |
| Dec 31, 2017 | -0.85% |
| Sep 30, 2017 | -1.35% |
| Sep 30, 2017 | -1.35% |
| Sep 30, 2017 | -1.35% |
| Jun 30, 2017 | -2.31% |
| Jun 30, 2017 | -2.31% |
| Jun 30, 2017 | -2.31% |
| Dec 31, 2013 | -2.65% |
| Dec 31, 2013 | -2.65% |
| Dec 31, 2013 | -2.65% |
| Sep 30, 2013 | -14.26% |
| Sep 30, 2013 | -14.26% |
| Sep 30, 2013 | -14.26% |
| Jun 30, 2013 | -19.13% |
| Jun 30, 2013 | -19.13% |
| Jun 30, 2013 | -19.13% |
| Mar 31, 2013 | 22.91% |
| Mar 31, 2013 | 22.91% |